Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
CBG-MEB · 5 medicines
AEMPS · 2 medicines
FDA · 2 medicines
HSA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
7 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Teva-Naratriptan | Canada | 1 MG | Tablet | Marketed | Teva Canada Limited |
| Teva-Naratriptan | Canada | 2.5 MG | Tablet | Marketed | Teva Canada Limited |
| Apo-Naratriptan | Canada | 1 MG | Tablet | Authorised | Apotex INC |
| Apo-Naratriptan | Canada | 2.5 MG | Tablet | Authorised | Apotex INC |
| Sandoz Naratriptan | Canada | 2.5 MG | Tablet | Marketed | Sandoz Canada Incorporated |
| Amerge | Canada | 2.5 MG | Tablet | Cancelled | Glaxosmithkline INC |
| Amerge | Canada | 1 MG | Tablet | Cancelled | Glaxosmithkline INC |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, Anvisa, CBG-MEB, FDA, Health Canada and HSA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
